Sorafenib in Advanced Hepatocellular Carcinoma
In patients with advanced hepatocellular carcinoma, median survival and the time to radiologic progression were nearly 3 months longer for patients treated with sorafenib than f...
Publications
2 shownFrequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 15,107
- Institution
- UCLouvain
External Links
Identifiers
- ORCID
- 0000-0001-7598-214X
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.